Congenital Abnormalities: Clinical Trials

8,239 trials for Congenital Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4093 completed, 1273 unknown, 1153 recruiting, 572 terminated. 2845 Not applicable, 1172 Phase 2, 645 Phase 1, 515 Phase 3, 274 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2845Completed 1392, Unknown 501, Recruiting 390, Not yet recruiting 201, Terminated 130, Active not recruiting 112, Withdrawn 68, Enrolling by invitation 43, Suspended 8
Phase 21172Completed 620, Terminated 156, Recruiting 121, Unknown 112, Withdrawn 56, Active not recruiting 55, Not yet recruiting 39, Suspended 7, Enrolling by invitation 6
Phase 1645Completed 377, Terminated 91, Recruiting 59, Unknown 42, Not yet recruiting 25, Withdrawn 23, Active not recruiting 22, Suspended 4, Enrolling by invitation 2
Phase 3515Completed 254, Terminated 74, Recruiting 64, Unknown 57, Active not recruiting 29, Not yet recruiting 16, Withdrawn 16, Suspended 3, Enrolling by invitation 2
Phase 4274Completed 130, Unknown 55, Terminated 28, Recruiting 26, Withdrawn 13, Not yet recruiting 11, Active not recruiting 8, Enrolling by invitation 2, Suspended 1
Early Phase 167Completed 29, Recruiting 9, Unknown 9, Terminated 7, Not yet recruiting 5, Withdrawn 4, Active not recruiting 2, Enrolling by invitation 2

Follow Congenital Abnormalities: new trials by email Literature Review of Congenital Abnormalities trials Research Report on Congenital Abnormalities

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Parenting Program for Young Children With Spina Bifida
Positive Parenting Program - Spina Bifida
Not applicableNot yet recruitingPhoenix Children's Hospital302028-01-012026-11-04
Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT
Trametinib - HCM, Noonan Syndrome and Other Rasopathy
Phase 3Not yet recruitingCarelon Research252027-08-012026-09-14
Epidermal Growth Factor Receptor Inhibition for Keratinopathies
Erlotinib - Epidermolytic Ichthyosis, Palmoplantar Keratoderma
Phase 1 / Phase 2Not yet recruitingNorthwestern University442027-07-012026-08-03
Continuous Passive Motion Device for Children With Arthrogryposis
CPM device - Arthrogryposis
Not applicableNot yet recruitingNemours Children's Clinic52027-06-012026-11-04
Nano Silver Fluoride and Photobiomodulation Therapy for Hypersensitivity and Pain in MIH-Affected Molars
Nano Silver Fluoride, Photobiomodulation Therapy, Pre-appointment analgesics - Molar-Incisor Hypomineralization (MIH)
Not applicableNot yet recruitingAin Shams University452027-05-012026-09-17
Indications and Evaluation of Microfat Grafting in Cleft Lip Nasal Deformities
Microfat grafting - Cleft Lip and Nose
Not applicableNot yet recruitingAssiut University302027-05-012026-10-29
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
scAAV1.tMCK.NTF3 - Charcot-Marie-Tooth Neuropathy Type 1A
Phase 1 / Phase 2WithdrawnNationwide Children's Hospital2027-04-012026-07-29
TORCH-LATAM-003: Regional Advanced-Therapy Pathways for Congenital Heart Disease
TORCH Congenital Advanced Therapies Pathway (TORCH-CATP) - Congenital Heart Disease, Advanced Heart Failure
Not applicableNot yet recruitingCardioVision International Tech, S.A.S. de C.V.3602027-03-302026-10-13
WSO BEAT STROKE Initiative
Educational and implementation Neurocardiology tool, No educational or implementation tool will be provided - Stroke, PFO - Patent Foramen Ovale
Not applicableNot yet recruitingLuciano A. Sposato24002027-03-012026-09-18
An Exercise and Lifestyle Programme for Adults With Vascular Ehlers-Danlos Syndrome: A Feasibility Study
Co-designed exercise-based lifestyle intervention - Vascular Ehlers Danlos Syndrome
Not applicableNot yet recruitingSheffield Hallam University402027-03-012026-07-13
TORCH-LATAM: A Regional Pathway to Improve Transplant Evaluation for Congenital Heart Disease
TORCH Integrated Transplant Access Pathway (TORCH-ITAP) - Congenital Heart Disease
Not applicableNot yet recruitingCardioVision International Tech, S.A.S. de C.V.6002027-03-012026-10-13
The Effect of Bitewing Radiography on Outcomes and Costs of Treating Caries in Permanent Teeth
Visual-tactile caries examination, Visual-tactile caries examination and bilateral bitewing radiography - Dental Caries, Teeth Loss
Not applicableNot yet recruitingJukka Leinonen2502027-03-012026-10-20
Topical TOR-582 Treatment of Epistaxis in HHT
Topical sirolimus ointment - Hereditary Hemorrhagic Telangiectasia (HHT), Epistaxis
Phase 1Not yet recruitingColumbia University272027-03-012026-11-06
Fetal Embolization for Severe Vein of Galen Malformation - A Feasibility and Safety Trial
Fetal embolization of severe Vein of Galen Malformation using a liquid embolic system - Vein of Galen Malformation
Not applicableNot yet recruitingMichael A Belfort102027-03-012026-11-10
S-TiUltra Implant Study
NobelReplace S-TiUltra, NobelReplace TiUnite - Missing Tooth/Teeth
Phase 4Not yet recruitingUniversity of Maryland, Baltimore302027-02-012026-11-02
A Pilot Study to Examine the Efficacy and Tolerability of Sirolimus on Epidermal Nevi Lesions in Patients 6 Years Old and Above.
sirolimus topical gel 0.2% - Epidermal Nevi
Early Phase 1Not yet recruitingNorthwestern University142027-02-012026-11-09
A Study to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy of S247240 in Adult Male Participants With Fragile X Syndrome
S247240 Low dose, S247240 Middle dose, S247240 High dose - Fragile X Syndrome (FXS)
Phase 2Not yet recruitingInstitut de Recherches Internationales Servier (I.R.I.S.)1002027-01-252026-11-12
Regenerative Medicine for Joint Hypermobility and Instability
Dextrose 20% Prolotherapy, Autologous Platelet-Rich Plasma, Doxycycline Hyclate Injectable (Investigational) - Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS)
Phase 1 / Phase 2Not yet recruitingManhattan Pain Medicine, PLLC1002027-01-152026-10-06
Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults
Mirdametinib - LGCMN, Large and Giant Congenital Melanocytic Nevi
Phase 2Not yet recruitingNational Cancer Institute (NCI)152027-01-042026-10-29
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
Autologous tissue engineered corpora - Urologic Diseases, Male Urogenital Diseases
Phase 1Not yet recruitingWake Forest University Health Sciences102027-01-012026-10-23

Showing 20 of 8239. Sign in to see all of them.

Narrower conditions

Heart Defects, Congenital (991)  ·  Down Syndrome (433)  ·  Leukemia, Myeloid, Acute (375)  ·  Leukemia (249)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (231)  ·  Arteriovenous Fistula (224)  ·  Polycystic Kidney, Autosomal Dominant (184)  ·  Hereditary Sensory and Autonomic Neuropathies (175)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (173)  ·  Flatfoot (167)  ·  Myeloproliferative Disorders (165)  ·  Leukemia, Myeloid, Accelerated Phase (163)  ·  Myelodysplastic Syndromes (161)  ·  Lymphoma, Follicular (160)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8213)  ·  Cardiovascular Diseases (3074)  ·  Cardiovascular Abnormalities (2626)  ·  Genetic Diseases, Inborn (2612)  ·  Nervous System Diseases (2193)  ·  Pathological Conditions, Signs and Symptoms (2113)  ·  Heart Diseases (2071)  ·  Musculoskeletal Diseases (1470)  ·  Abnormalities, Multiple (1428)  ·  Urogenital Diseases (1257)  ·  Female Urogenital Diseases and Pregnancy Complications (1205)  ·  Musculoskeletal Abnormalities (1177)  ·  Neurologic Manifestations (1165)  ·  Pathologic Processes (1163)

Interventions

Cytarabine (95)  ·  fludarabine phosphate (95)  ·  Cyclophosphamide (84)  ·  Blood Specimen Collection (82)  ·  Peripheral Blood Stem Cell Transplantation (79)  ·  Busulfan (69)  ·  Tacrolimus (61)  ·  Mycophenolic Acid (59)  ·  Cyclosporine (56)  ·  Sirolimus (55)  ·  Surveys and Questionnaires (55)  ·  Saline Solution (52)  ·  Whole-Body Irradiation (50)  ·  Sodium Chloride (49)  ·  Antilymphocyte Serum (47)

Sponsors

Assiut University (128)  ·  Cairo University (125)  ·  Assistance Publique - Hôpitaux de Paris (116)  ·  Boston Children's Hospital (83)  ·  National Cancer Institute (NCI) (79)  ·  Riphah International University (67)  ·  Hospices Civils de Lyon (65)  ·  Mayo Clinic (60)  ·  Children's Hospital Medical Center, Cincinnati (58)  ·  University of Colorado, Denver (53)  ·  Fred Hutchinson Cancer Center (52)  ·  Stanford University (50)  ·  University Hospital, Montpellier (50)  ·  The Hospital for Sick Children (49)  ·  Emory University (43)

Countries

United States (3120)  ·  France (893)  ·  Canada (482)  ·  China (452)  ·  Italy (436)  ·  United Kingdom (434)  ·  Turkey (Türkiye) (397)  ·  Germany (383)  ·  Egypt (360)  ·  Spain (326)  ·  Netherlands (242)  ·  Belgium (221)  ·  Australia (177)  ·  Denmark (161)  ·  Brazil (151)

Top investigators

David Meeker, MD (11)  ·  Forbes D Porter, M.D. (7)  ·  Judith Karp (7)  ·  Amy Paller, MD (6)

Results publications

PMID 39356039, PMID 41385299, PMID 22587997, PMID 37250503, PMID 24383844, PMID 25527568, PMID 31375516, PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 32499241, PMID 33112424, PMID 36184192, PMID 40938675, PMID 41348481, PMID 17284531, PMID 21306277, PMID 30936738, PMID 33159213, PMID 35029841, PMID 35080267, PMID 36184076, PMID 36191725, PMID 36978128, PMID 37349694, PMID 37979797, PMID 38837240, PMID 12084585, PMID 18000608, PMID 22065264, PMID 24586400, PMID 26554876, PMID 29023494, PMID 29718281, PMID 30935731, PMID 31014270, PMID 32034419, PMID 33395098, PMID 33527139, PMID 34783716, PMID 36214650, PMID 36519620, PMID 37460782, PMID 38671361, PMID 41491634, PMID 42002216, PMID 12401454, PMID 15100156

NIH funding

2023 (28), P30CA015704 (26), 2025 (22), 2017 (20), 2018 (18), P30CA006973 (17), 2015 (16), 2016 (16), 2019 (16), P30CA043703 (16), U10CA032102 (16), P30CA033572 (14), U01CA070095 (12), P30CA072720 (11), 2008 (9)